Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.16
- Piotroski Score 6.00
- Grade Buy
- Symbol (GDRX)
- Company GoodRx Holdings, Inc.
- Price $4.30
- Changes Percentage (1.42%)
- Change $0.06
- Day Low $4.18
- Day High $4.32
- Year High $9.26
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $10.00
- High Stock Price Target $45.00
- Low Stock Price Target $3.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.01
- Trailing P/E Ratio -855
- Forward P/E Ratio -855
- P/E Growth -855
- Net Income $-8,868,000
Income Statement
Quarterly
Annual
Latest News of GDRX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ...
Scott Wagner addresses retail market challenges by leveraging industry knowledge, directing consumers to new pharmacies, and providing value. Karsten Voermann notes Pharma manufacturer solutions growt...
By Yahoo! Finance | 1 week ago -
GoodRx (GDRX) Q3 2024 Earnings Call Transcript
GoodRx has seen growth in pharma solutions like Biosimilar Humira and is working on maximizing value for shareholders. Despite retail pharmacy challenges, their value proposition remains strong. They ...
By Yahoo! Finance | 1 week ago -
GoodRx (GDRX) Q2 2024 Earnings Call Transcript
GoodRx discussed their second-quarter earnings call, addressing topics like the impact of pharmacy closures, expansion of programs like ISP, and relationships with independent pharmacies. The company ...
By Yahoo! Finance | 3 months ago
